var title_f1_5_1104="Breast development and milk lines";
var content_f1_5_1104=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F63944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F63944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Breast development and milk lines",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 417px; height: 580px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Polymastia (supernumerary breasts) and polythelia (supernumerary nipples) may develop in males and females anywhere along the length of the mammary ridges (milk lines). Breast tissue may not develop (amastia) or there may be nipple development but no breast tissue (amazia).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1104=[""].join("\n");
var outline_f1_5_1104=null;
var title_f1_5_1105="Approach to cervical adenopathy in children";
var content_f1_5_1105=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73804&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73804&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 634px\">",
"   <div class=\"ttl\">",
"    Suggested approach to cervical adenopathy in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 614px; height: 599px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CBC: complete blood count; ESR: erythrocyte sedimentation rate; PPD: purified protein derivative test for tuberculosis.",
"     <br>",
"      * Empiric antibiotic therapy should include coverage for common pathogens such as group A streptococcus and",
"      <em>",
"       Staphylococcus aureus",
"      </em>",
"      .&nbsp;Examples include clindamycin in areas with a high prevalence of community-associated methicillin-resistant",
"      <em>",
"       S. aureus",
"      </em>",
"      (CA-MRSA) or a first-generation cephalosporin (eg, cephalexin) or amoxicillin-clavulanate in areas with a low prevalence of CA-MRSA.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Based on information from:",
"     <br>",
"      <ol>",
"       <li>",
"        Soldes OS, Younger JG, Hirschl RB. Predictors of malignancy in childhood peripheral lymphadenopathy. J Pediatr Surg 1999; 34:1447.",
"       </li>",
"       <li>",
"        Slap GB, Brooks JS, Schwartz JS. When to perform biopsies of enlarged peripheral lymph nodes in young patients. JAMA 1984; 252:1321.",
"       </li>",
"      </ol>",
"      <br/>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1105=[""].join("\n");
var outline_f1_5_1105=null;
var title_f1_5_1106="Radiographic features of pelvic instability";
var content_f1_5_1106=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F68903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F68903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 602px\">",
"   <div class=\"ttl\">",
"    Radiographic features of pelvic instability",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 582px; height: 298px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A standing AP radiograph of pelvis shows findings associated with underlying pelvic instability: (1) pelvic tilt secondary to leg length discrepancy; (2) degenerative changes at the symphysis pubis which include joint space narrowing, articular cortical irregularity and subchondral sclerosis; (3) slight pubic malalignment with associated traction osteophyte at the superior joint margin; (4) widening of the right sacroiliac joint inferiorly (arrowhead); and (5) ossification at the left adductor origin secondary to an old tear (arrow). Not all such changes are seen in all cases.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Read JW. Groin disruption injury. Sports Medicine Imaging. For more information, visit",
"     <a href=\"file://www.sportsmedicineimaging.com/Home.html\" target=\"_blank\">",
"      file://www.sportsmedicineimaging.com/Home.html",
"     </a>",
"     . Copyright &copy; 2009 SportsMedicineImaging.com. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1106=[""].join("\n");
var outline_f1_5_1106=null;
var title_f1_5_1107="Circumcision in baby boys";
var content_f1_5_1107=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Circumcision in baby boys (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/5/1107/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1107/contributors\" id=\"au6027\">",
"       Laurence S Baskin, MD, FAAP",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/5/1107/contributors\">",
"       Section Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1107/contributors\" id=\"se4723\">",
"       Charles J Lockwood, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1107/contributors\" id=\"se8628\">",
"       Duncan Wilcox, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/5/1107/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1107/contributors\" id=\"de4555\">",
"       Vanessa A Barss, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?1/5/1107?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      CIRCUMCISION OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Circumcision in the male is the removal of the foreskin of the penis. The practice of circumcision dates to ancient times. In ancient Egypt, prior to biblical times, circumcision was performed to improve male hygiene. Later, routine circumcision of male infants was part of the Abrahamic covenants with Jehovah, giving rise to religious circumcisions that continue to this day in the Jewish and Muslim faiths.",
"    </p>",
"    <p>",
"     Circumcision rates in the United States vary according to geographic area, socioeconomic status, religious affiliation, insurance coverage, hospital type, and racial and ethnic group. The incidence in 2008 was about 55 to 57 percent based on hospital coding data, but this is probably an underestimate of the true incidence of circumcised males, which is likely closer to 80 percent, due to miscoding and because some circumcisions are performed after hospital discharge or later in life for religious, medical, or personal reasons [",
"     <a class=\"abstract\" href=\"UTD.htm?1/5/1107/abstract/1\">",
"      1",
"     </a>",
"     ]. Based on coding data, circumcision rates are highest in the Midwestern states (74 percent), followed by the Northeastern states (67 percent) and Southern states (61 percent), and are lowest in the Western states (30 percent).",
"    </p>",
"    <p>",
"     There are no studies that give reliable data about the number of males who are circumcised after birth for elective or surgical indications. An Australian survey found that approximately 18 percent of males who were not circumcised as infants reported that they were circumcised subsequently [",
"     <a class=\"abstract\" href=\"UTD.htm?1/5/1107/abstract/2,3\">",
"      2,3",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11166471\">",
"     <span class=\"h1\">",
"      NORMAL PENILE DEVELOPMENT AND HYGIENE",
"     </span>",
"    </p>",
"    <p>",
"     At birth, the foreskin, sometimes called the prepuce, is attached to the end of the penis, an area known as the glans (",
"     <a class=\"graphic graphic_picture graphicRef69361 \" href=\"UTD.htm?22/55/23423\">",
"      picture 1",
"     </a>",
"     ). Over time, the foreskin separates from the glans, forming a space between the skin and the glans. Separation is completed in 50 percent of boys by age 3 years, 95 percent by age 5 years, and 99 percent by adolescence. In a small number of uncircumcised males, partial adhesions leading to accumulation of smegma may persist throughout childhood, and even into adolescence.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Care of an uncircumcised penis",
"     </span>",
"     &nbsp;&mdash;&nbsp;The foreskin should never be forcibly pulled back when there is resistance. Forcibly retracting the foreskin while it is still attached to the glans could cause injury.",
"    </p>",
"    <p>",
"     The uncircumcised penis is generally easy to keep clean. Parents of an infant should gently wash the genital area while bathing. Later, when the foreskin is fully retractable, boys should be taught the importance of washing beneath the foreskin on a regular basis. The foreskin should be dried before pulling it forward.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      BENEFITS OF CIRCUMCISION",
"     </span>",
"    </p>",
"    <p>",
"     There are several medical benefits to male circumcision. However, factors other than circumcision (eg, number of sexual partners, use of condoms, human papillomavirus (HPV) immunization, penile hygiene) are probably much more important risk factors for penile medical disorders than not being circumcised.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Reduction in urinary tract infection",
"     </span>",
"     &nbsp;&mdash;&nbsp;Urinary tract infections (UTIs) are uncommon in males; the greatest risk is in male infants less than one year old. Studies consistently report that uncircumcised male infants are at higher risk of UTI compared with circumcised male infants. UTIs in infants can result in kidney infection requiring hospitalization and, rarely, severe infection and death. If the urinary tract is normal, long-term sequelae from UTI are unlikely.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Cancer",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cancer of the penis is rare, but uncircumcised men are at increased risk for developing the disease. Good hygiene and HPV immunization may reduce or negate this risk.",
"    </p>",
"    <p>",
"     Cervical cancer is more common in women whose male sexual partners are not circumcised. HPV immunization may reduce or negate this risk.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Penile problems",
"     </span>",
"     &nbsp;&mdash;&nbsp;Uncircumcised males are at increased risk for inflammation of the glans; this problem rarely occurs in circumcised men, as well. Uncircumcised boys who practice good penile hygiene are less likely to experience penile inflammation.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Infection",
"     </span>",
"     &nbsp;&mdash;&nbsp;Studies suggest that circumcision helps decrease the risk of acquisition of human immunodeficiency virus (HIV), HPV, and probably herpes simplex virus type 2 (HSV-2), and also some evidence that it may protect against trichomonas and chancroid infection. Circumcision does not protect against infection from gonorrhea, chlamydia trachomatis, or syphilis. It is important to note, however, that many circumcised men acquire these diseases. Circumcision may lower the risk of acquiring the infection, but it does not eliminate it.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Hygiene",
"     </span>",
"     &nbsp;&mdash;&nbsp;In the uncircumcised male, the space between the foreskin and the glans must be cleaned regularly. Proponents of circumcision argue that it is difficult for uncircumcised boys and men to maintain proper hygiene.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      ADVERSE EFFECTS OF CIRCUMCISION",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Procedural risks",
"     </span>",
"     &nbsp;&mdash;&nbsp;An accurate complication rate is difficult to determine because the largest studies are based on coding diagnoses and inconsistent definitions. In addition, data have generally not been stratified to account for timing of the procedure, technique, provider type, setting, length of follow-up, timing of complications, and severity of complications.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       In two studies that included a total of over 200,000 circumcisions performed in United States hospitals, the rate of complications during and in the first month after the procedure was approximately 0.2 percent [",
"       <a class=\"abstract\" href=\"UTD.htm?1/5/1107/abstract/4,5\">",
"        4,5",
"       </a>",
"       ].",
"      </li>",
"      <li>",
"       A systematic review identified 16 prospective studies of complications following neonatal and infant circumcision by a variety of providers from 12 countries and primarily using the Plastibell [",
"       <a class=\"abstract\" href=\"UTD.htm?1/5/1107/abstract/6\">",
"        6",
"       </a>",
"       ]. The median frequency of any adverse event was 1.5 percent (range 0 to 16 percent) and the median frequency of any serious adverse event was 0 percent (range 0 to 2 percent); nine studies reported no serious adverse events, but three studies reported that 1 to 2 percent of boys had a serious complication. Complication rates were slightly lower in 10 retrospective studies.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <span class=\"nowrap\">",
"      Complications/sequelae",
"     </span>",
"     of circumcision include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Inadequate skin removal, which may result in an unsatisfactory cosmetic appearance and revision of the procedure. This is a common complaint, although the frequency is poorly documented in the literature.",
"      </li>",
"      <li>",
"       Bleeding, which is usually mild and controlled with local pressure, but surgical intervention and transfusion may be required on rare occasions.",
"      </li>",
"      <li>",
"       Infection, which is usually mild and treated by local antibiotics, but sepsis can occur and death has been reported.",
"      </li>",
"      <li>",
"       Urethral complications, including urethrocutaneous fistula and meatal stenosis. Meatal stenosis can occur when urine from a wet diaper irritates the exposed ventral urethral meatus of the circumcised penis.",
"      </li>",
"      <li>",
"       Glans injury, including penile amputation",
"      </li>",
"      <li>",
"       Removal of excessive skin, which may result in a denuded penile shaft",
"      </li>",
"      <li>",
"       Epidermal inclusion cyst",
"      </li>",
"      <li>",
"       Adhesions, which range from mild to dense (also referred to as skin bridges)",
"      </li>",
"      <li>",
"       Cicatrix (a circumferential scar that usually develops at the incision line and is often associated with a hidden penis)",
"      </li>",
"      <li>",
"       Complications from anesthesia",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Other considerations",
"     </span>",
"     &nbsp;&mdash;&nbsp;The prepuce contains specialized sensory tissue that is removed during circumcision. Some men believe that the end of the penis becomes less sensitive when the foreskin is removed and that sexual sensation may be decreased. However, most circumcised males do not describe psychological trauma or decreased sexual function or desire as a result of the procedure.",
"    </p>",
"    <p>",
"     Parents should be aware that some health plans do not cover the cost of circumcision. Parents should call their health plan directly to find out if the procedure is covered.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      PAIN CONTROL DURING CIRCUMCISION",
"     </span>",
"    </p>",
"    <p>",
"     Studies in newborns have shown that signs of",
"     <span class=\"nowrap\">",
"      stress/pain",
"     </span>",
"     occur during the circumcision procedure. These include crying, increased heart rate, and increased blood pressure.",
"    </p>",
"    <p>",
"     Parents should discuss what pain control measures will be used before their child is circumcised. The American Academy of Pediatrics (AAP) recommends that all infants undergoing circumcision have adequate pain control during and after the procedure [",
"     <a class=\"abstract\" href=\"UTD.htm?1/5/1107/abstract/7\">",
"      7",
"     </a>",
"     ]. The American College of Obstetricians and Gynecologists (ACOG) supports the conclusions of the AAP and also states that pain control should be provided. Swaddling, oral sugar solutions, or acetaminophen may be given as well, but should not be used as the primary method of pain relief.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      CIRCUMCISION PREPARATION AND PROCEDURE",
"     </span>",
"    </p>",
"    <p>",
"     Before circumcision, the doctor who will perform the procedure will review the informed consent. This is a discussion of the reasons for circumcision, the benefits, risks, and alternatives, and ensures that the parents understand what will happen during the procedure.",
"    </p>",
"    <p>",
"     There are a few situations that may cause a circumcision to be delayed. For example, in babies who are born prematurely, circumcision is usually delayed until they are ready to be discharged from the hospital. Babies who are born with a defect of the penis should be evaluated by a urologist, who may recommend delaying circumcision. If there is a family history of a bleeding disorder or the baby has bleeding problems, circumcision is delayed until it has been determined that the baby is not at increased risk of bleeding during the procedure.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Technique",
"     </span>",
"     &nbsp;&mdash;&nbsp;The infant is placed in a restraint (",
"     <a class=\"graphic graphic_picture graphicRef57702 \" href=\"UTD.htm?10/8/10369\">",
"      picture 2",
"     </a>",
"     ). The penis and an area of skin around the base of the penis are thoroughly cleaned.",
"    </p>",
"    <p>",
"     There are several techniques for performing circumcision; the choice of which technique is used depends upon the physician's preference and experience. The three major methods of circumcision are the Gomco clamp, the Plastibell device, and the Mogen clamp. The procedure takes about 15 to 30 minutes.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Post-procedure care",
"     </span>",
"     &nbsp;&mdash;&nbsp;After the circumcision is completed, a gauze dressing is usually applied (",
"     <a class=\"graphic graphic_picture graphicRef78348 graphicRef68621 \" href=\"UTD.htm?2/2/2087\">",
"      picture 3A-B",
"     </a>",
"     ). Use of a lubricant under the gauze helps to prevent it from sticking to the glans. The gauze should be removed and replaced with every diaper change for 24 hours. The circumcision site is cleaned with warm water and a cotton ball once or twice a day. Normally the infant urinates within 12 hours of the procedure.",
"    </p>",
"    <p>",
"     After the first 24 hours, the gauze is omitted and the lubricant is applied directly to the penis for three to five days. This helps keep the area clean and keeps the wound site from adhering to the diaper. At first, the penis will appear red (",
"     <a class=\"graphic graphic_picture graphicRef74651 \" href=\"UTD.htm?14/52/15183\">",
"      picture 4",
"     </a>",
"     ). In a few days, a soft yellow scab will develop. This is normal and will go away in a few days. During this process, parents should watch for worsening redness, swelling, bleeding (larger than a quarter-size on the diaper) or drainage that does not go away. Any of these signs should prompt a call to the infant's healthcare provider.",
"    </p>",
"    <p>",
"     Usually the penis needs no further care once it has healed.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      PUBLIC AND PROFESSIONAL OPINIONS ON CIRCUMCISION",
"     </span>",
"    </p>",
"    <p>",
"     Professional societies and lay groups have expressed a wide range of views concerning the advantages and disadvantages of routine circumcision.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       In 2012, the",
"       <a class=\"external\" href=\"file://pediatrics.aappublications.org/content/early/2012/08/22/peds.2012-1990\">",
"        American Academy of Pediatrics",
"       </a>",
"       (AAP) task force on circumcision of the male infant concluded that \"the health benefits of newborn male circumcision outweigh the risks; furthermore, the benefits of newborn male circumcision justify access to this procedure for families who choose it. Specific benefits from male circumcision were identified for the prevention of urinary tract infections, acquisition of HIV, transmission of some sexually transmitted infections, and penile cancer. Male circumcision does not appear to adversely affect penile sexual",
"       <span class=\"nowrap\">",
"        function/sensitivity",
"       </span>",
"       or sexual satisfaction&rdquo; [",
"       <a class=\"abstract\" href=\"UTD.htm?1/5/1107/abstract/7\">",
"        7",
"       </a>",
"       ]. Compared to their previous statement, this statement is a stronger affirmation of the health benefits of circumcision. However, the AAP did not recommend routine circumcision. They said, &ldquo;Parents should weigh the health benefits and risks in light of their own religious, cultural, and personal preferences, as the medical benefits alone may not outweigh these other considerations for individual families&rdquo; [",
"       <a class=\"abstract\" href=\"UTD.htm?1/5/1107/abstract/7\">",
"        7",
"       </a>",
"       ].",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      MAKING A DECISION ABOUT CIRCUMCISION",
"     </span>",
"    </p>",
"    <p>",
"     Making the decision to circumcise an infant can be difficult for some parents. A father may be concerned that his son's penis appear similar to himself or to other men. Some parents may be concerned about the risks versus the benefits of the procedure. Other parents have no difficulty making a decision because of cultural or religious rules that require circumcision.",
"    </p>",
"    <p>",
"     A decision is best made before the baby is born, although parents should feel comfortable discussing their questions or concerns with their healthcare provider after the child's birth. The procedure can be performed at the hospital before the mother and baby are discharged, or can be performed as an outpatient procedure with local anesthesia as late as three months after birth. After three months, the procedure usually requires general anesthesia.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your child's healthcare provider is the best source of information for questions and concerns related to your child's medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed every on our Web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27017692\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27017699\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/36/29249?source=see_link\">",
"      Patient information: Circumcision in baby boys (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/48/41729?source=see_link\">",
"      Patient information: Caring for an uncircumcised penis (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27017732\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     This topic currently has no corresponding Beyond the Basics content.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27017746\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41705?source=see_link\">",
"      Neonatal circumcision: Risks and benefits",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15256?source=see_link\">",
"      Techniques for neonatal circumcision",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4903?source=see_link\">",
"      Complications of circumcision",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11559?source=see_link\">",
"      Care of the uncircumcised penis",
"     </a>",
"    </p>",
"    <p>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/circumcision.html\">",
"      www.nlm.nih.gov/medlineplus/circumcision.html",
"     </a>",
"     , available in many languages)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Pediatrics, Care of the Uncircumcised Penis",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cirp.org/library/normal/aap/\">",
"      www.cirp.org/library/normal/aap/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Mayo Clinic",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.mayoclinic.com/health/circumcision/MY01023\">",
"      file://www.mayoclinic.com/health/circumcision/MY01023",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?1/5/1107/abstract/8-11\">",
"      8-11",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 22, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?1/5/1107?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/1\">",
"      Blank S, Brady M, Buerk E, et al. Male circumcision. Pediatrics 2012; 130:e756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/2\">",
"      Badger, J. Circumcision. What you think. Australian Forum 1989; 2:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/3\">",
"      Badger, J. The great circumcision report part 2. Australian Forum 1989; 2:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/4\">",
"      Wiswell TE, Geschke DW. Risks from circumcision during the first month of life compared with those for uncircumcised boys. Pediatrics 1989; 83:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/5\">",
"      Christakis DA, Harvey E, Zerr DM, et al. A trade-off analysis of routine newborn circumcision. Pediatrics 2000; 105:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/6\">",
"      Weiss HA, Larke N, Halperin D, Schenker I. Complications of circumcision in male neonates, infants and children: a systematic review. BMC Urol 2010; 10:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/7\">",
"      American Academy of Pediatrics Task Force on Circumcision. Circumcision policy statement. Pediatrics 2012; 130:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/8\">",
"      Taddio A, Stevens B, Craig K, et al. Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision. N Engl J Med 1997; 336:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/9\">",
"      Circumcision policy statement. American Academy of Pediatrics. Task Force on Circumcision. Pediatrics 1999; 103:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/10\">",
"      Lander J, Brady-Fryer B, Metcalfe JB, et al. Comparison of ring block, dorsal penile nerve block, and topical anesthesia for neonatal circumcision: a randomized controlled trial. JAMA 1997; 278:2157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1107/abstract/11\">",
"      Schoen EJ. Ignoring evidence of circumcision benefits. Pediatrics 2006; 118:385.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f1_5_1107=[""].join("\n");
var outline_f1_5_1107=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           CIRCUMCISION OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11166471\">",
"           NORMAL PENILE DEVELOPMENT AND HYGIENE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           BENEFITS OF CIRCUMCISION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           ADVERSE EFFECTS OF CIRCUMCISION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           PAIN CONTROL DURING CIRCUMCISION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           CIRCUMCISION PREPARATION AND PROCEDURE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           PUBLIC AND PROFESSIONAL OPINIONS ON CIRCUMCISION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           MAKING A DECISION ABOUT CIRCUMCISION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/55/23423\" title=\"picture 1\">",
"           Uncircumcised penis PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/8/10369\" title=\"picture 2\">",
"           Circumcision restraint PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/1/5139\" title=\"picture 3A\">",
"           Petroleum gauze PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/8/17536\" title=\"picture 3B\">",
"           Petroleum gauze dressing PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/52/15183\" title=\"picture 4\">",
"           Circumcised penis PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f1_5_1108="Lactobacillus: Pediatric drug information";
var content_f1_5_1108=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lactobacillus: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"    see \"Lactobacillus: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?18/6/18532?source=see_link\">",
"    see \"Lactobacillus: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F186486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Bacid&reg; [OTC];",
"     </li>",
"     <li>",
"      Culturelle&reg; [OTC];",
"     </li>",
"     <li>",
"      Dofus [OTC];",
"     </li>",
"     <li>",
"      Flora-Q&trade; [OTC];",
"     </li>",
"     <li>",
"      Floranex&trade; [OTC];",
"     </li>",
"     <li>",
"      Kala&reg; [OTC];",
"     </li>",
"     <li>",
"      Lactinex&trade; [OTC];",
"     </li>",
"     <li>",
"      Lacto-Bifidus [OTC];",
"     </li>",
"     <li>",
"      Lacto-Key [OTC];",
"     </li>",
"     <li>",
"      Lacto-Pectin [OTC];",
"     </li>",
"     <li>",
"      Lacto-TriBlend [OTC];",
"     </li>",
"     <li>",
"      Megadophilus&reg; [OTC];",
"     </li>",
"     <li>",
"      MoreDophilus&reg; [OTC];",
"     </li>",
"     <li>",
"      RisaQuad&reg;-2 [OTC];",
"     </li>",
"     <li>",
"      RisaQuad&trade; [OTC];",
"     </li>",
"     <li>",
"      Superdophilus&reg; [OTC];",
"     </li>",
"     <li>",
"      VSL #3&reg; [OTC];",
"     </li>",
"     <li>",
"      VSL #3&reg;-DS",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F186487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Bacid&reg;;",
"     </li>",
"     <li>",
"      Fermalac",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1059615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidiarrheal",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1059612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"      see \"Lactobacillus: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children and Adults: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule: 1-2 capsules 2-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Granules: 1 packet added to or taken with cereal, food, milk, fruit juice, or water 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder:",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     -1 teaspoon 1-3 times/day with liquid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable: 4 tablets 3-4 times/day; may follow each dose with a small amount of milk, fruit juice, or water",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Recontamination protocol for BMT unit: 1 packet 3 times/day for 6 doses for those patients who refuse yogurt",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F186472\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Culturelle&reg;:",
"     <i>",
"      L. rhamnosus",
"     </i>",
"     GG 10 billion colony-forming units [contains casein and whey]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Dofus:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L. bifidus",
"     </i>",
"     10:1 ratio [beet root powder base]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Flora-Q&trade;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L.  paracasei",
"     </i>",
"     &ge;8 billion colony-forming units [also contains",
"     <i>",
"      Bifidobacterium",
"     </i>",
"     and",
"     <i>",
"      S. thermophilus",
"     </i>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Lacto-Key:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     100:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     1 billion colony-forming units [milk, soy, and yeast free; rice derived]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     600:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     6 billion colony-forming units [milk, soy, and yeast free; rice derived]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Lacto-Bifidus:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     100:",
"     <i>",
"      L. bifidus",
"     </i>",
"     1 billion colony-forming units [milk, soy, and yeast free; rice derived]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     600:",
"     <i>",
"      L. bifidus",
"     </i>",
"     6 billion colony-forming units [milk, soy, and yeast free; rice derived]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Lacto-Pectin:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L.  casei",
"     </i>",
"     &ge;5 billion colony-forming units [also contains",
"     <i>",
"      Bifidobacterium lactis",
"     </i>",
"     and citrus pectin cellulose complex]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Lacto-TriBlend:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     100:",
"     <i>",
"      L. acidophilus,  L. bifidus,",
"     </i>",
"     and",
"     <i>",
"      L. bulgaricus",
"     </i>",
"     1 billion colony-forming units [milk, soy and yeast free; rice derived]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     600:",
"     <i>",
"      L. acidophilus, L. bifidus,",
"     </i>",
"     and",
"     <i>",
"      L. bulgaricus",
"     </i>",
"     6 billion colony-forming units [milk, soy and yeast free; rice derived]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Megadophilus&reg;, Superdophilus&reg;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     2 billion units [available in dairy based or dairy free formulations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     RisaQuad&trade;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L. paracasei",
"     </i>",
"     8 billion colony-forming units [also includes",
"     <i>",
"      Bifidobacterium",
"     </i>",
"     and",
"     <i>",
"      Streptococcus thermophilus",
"     </i>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     VSL #3&reg;:",
"     <i>",
"      L. acidophilus, L. plantarum, L. paracasei, L. bulgaricus",
"     </i>",
"     112 billion live cells [also contains",
"     <i>",
"      Bifidobacterium breve, B. longum, B. infantis,",
"     </i>",
"     and",
"     <i>",
"      Streptococcus thermophilus",
"     </i>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, double strength:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     RisaQuad&reg;-2:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L. paracasei",
"     </i>",
"     16 billion colony-forming units [gluten free; also includes",
"     <i>",
"      Bifidobacterium",
"     </i>",
"     and",
"     <i>",
"      Streptococcus thermophilus",
"     </i>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Capsule, softgel:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     100 active units",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Caplet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Bacid&reg;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L. bulgaricus",
"     </i>",
"     [also contains",
"     <i>",
"      Bifidobacterium biffidum",
"     </i>",
"     and",
"     <i>",
"      Streptococcus  thermophilus",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Granules:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Floranex&trade;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L. bulgaricus",
"     </i>",
"     100 million live cells per 1 g packet (12s) [contains milk, sodium 5 mg/packet, soy]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lactinex&trade;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L. bulgaricus",
"     </i>",
"     100 million live cells per 1 g packet (12s) [gluten free; contains calcium 5 mg/packet, lactose 380 mg/packet, potassium 20 mg/packet, sodium 5 mg/packet, sucrose 34 mg/packet, whey, evaporated milk, and soy peptone]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Powder:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lacto-TriBlend:",
"     <i>",
"      L. acidophilus, L. bifidus,",
"     </i>",
"     and",
"     <i>",
"      L. bulgaricus",
"     </i>",
"     10 billion colony-forming units per &frac14; teaspoon (60 g) [milk, soy, and yeast free; rice derived]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Megadophilus&reg;, Superdophilus&reg;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     2 billion units per half-teaspoon (49 g, 70 g, 84 g, 126 g) [available in dairy based or dairy free (garbanzo bean) formulations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     MoreDophilus&reg;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     12.4 billion units per teaspoon (30 g, 120 g) [dairy free, yeast free; soy and carrot derived]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     VSL #3&reg;:",
"     <i>",
"      L. acidophilus, L. plantarum, L. paracasei, L. bulgaricus",
"     </i>",
"     450 billion live cells per sachet (10s, 30s) [gluten free; also contains",
"     <i>",
"      Bifidobacterium breve, B. longum, B. infantis",
"     </i>",
"     , and",
"     <i>",
"      Streptococcus thermophilus",
"     </i>",
"     ; lemon cream flavor and unflavored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     VSL #3&reg;-DS:",
"     <i>",
"      L. acidophilus, L. plantarum, L. paracasei, L. bulgaricus",
"     </i>",
"     900 billion live cells per packet (20s,) [gluten free; also contains",
"     <i>",
"      Bifidobacterium breve, B. longum, B. infantis",
"     </i>",
"     , and",
"     <i>",
"      Streptococcus thermophilus",
"     </i>",
"     ]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Tablet:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Kala&reg;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     200 million units [dairy free, yeast free; soy based]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Tablet, chewable:",
"     <i>",
"      L. reuteri",
"     </i>",
"     100 million organisms",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Floranex&trade;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L. bulgaricus",
"     </i>",
"     1 million colony-forming units [contains lactose, nonfat dried milk, whey]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Lactinex&trade;:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     and",
"     <i>",
"      L. bulgaricus",
"     </i>",
"     1 million live cells [gluten free; contains calcium 5.2 mg/4 tablets, lactose 960 mg/4 tablets, potassium 20 mg/4 tablets, sodium 5.6 mg/4 tablets, and sucrose  500 sucrose/4 tablets; contains whey, evaporated milk, and soy peptone]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Wafer:",
"     <i>",
"      L. acidophilus",
"     </i>",
"     90 mg and",
"     <i>",
"      L. bifidus",
"     </i>",
"     25 mg (100s) [provides 1 billion organisms/wafer at time of manufacture; milk free]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F186459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1059618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Granules, powder, or contents of capsules may be added to or administered with cereal, food, milk, fruit juice, or water",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1059614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store in the refrigerator",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1059617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of uncomplicated diarrhea particularly that caused by antibiotic therapy; re-establish normal physiologic and bacterial flora of the intestinal tract",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F186505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Gastrointestinal: Bloating (intestinal), flatulence",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1059621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Allergy to milk or lactose",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1059611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Discontinue if high fever present",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F186467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1059610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Creates an environment unfavorable to potentially pathogenic fungi or bacteria through the production of lactic acid, and favors establishment of an aciduric flora, thereby suppressing the growth of pathogenic microorganisms; helps re-establish normal intestinal flora",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1059620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Not orally absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Locally, primarily in the colon",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: In feces",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13404 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-0970125B04-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1108=[""].join("\n");
var outline_f1_5_1108=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186486\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186487\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059615\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059612\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186472\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186459\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059618\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059614\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059617\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186505\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059621\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059611\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299569\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186467\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059610\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059620\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13404\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13404|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=related_link\">",
"      Lactobacillus: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?18/6/18532?source=related_link\">",
"      Lactobacillus: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_5_1109="Lentigo maligna nose";
var content_f1_5_1109=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F59591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F59591&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lentigo maligna",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from:",
"     <a href=\"file://www.visualdx.com\" target=\"_blank\">",
"      www.visualdx.com",
"     </a>",
"     . Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1109=[""].join("\n");
var outline_f1_5_1109=null;
var title_f1_5_1110="Penicillins";
var content_f1_5_1110=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Penicillins",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/5/1110/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1110/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/5/1110/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1110/contributors\">",
"     David C Hooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/5/1110/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1110/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/5/1110/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta-lactam antibiotics are among the most commonly prescribed drugs, grouped together based upon a shared structural feature, the beta-lactam ring. The classification, spectrum of activity and pharmacology of one group of beta-lactam antibiotics, the penicillins, will be reviewed here. The mechanisms of action and resistance and major adverse reactions of the beta-lactam antibiotics are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/2/26663?source=see_link\">",
"     \"Beta-lactam antibiotics: Mechanisms of action and resistance and adverse effects\"",
"    </a>",
"    .) The cephalosporins and other beta-lactam drugs are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38519?source=see_link\">",
"     \"Cephalosporins\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44789?source=see_link\">",
"     \"Combination beta-lactamase inhibitors, carbapenems, and monobactams\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Penicillins can be classified into the following categories:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"       Penicillin G",
"      </a>",
"     </li>",
"     <li>",
"      Antistaphylococcal penicillins (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/36/1608?source=see_link\">",
"       nafcillin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"       oxacillin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/45/31446?source=see_link\">",
"       cloxacillin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=see_link\">",
"       dicloxacillin",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Broad spectrum penicillins: second generation (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"       ampicillin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      and related agents), third generation (carbenicillin and ticarcillin) and fourth generation (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"       piperacillin",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SPECTRUM OF ACTIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the major differences among the penicillins is the range of bacteria against which they are active.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Penicillin G",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"     Penicillin G",
"    </a>",
"    is highly active against:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Gram-positive cocci (except penicillinase-producing staphylococci, penicillin-resistant pneumococci [",
"      <a class=\"abstract\" href=\"UTD.htm?1/5/1110/abstract/1-5\">",
"       1-5",
"      </a>",
"      ], enterococci, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"       oxacillin",
"      </a>",
"      -resistant staphylococci) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/5/81?source=see_link\">",
"       \"Resistance of Streptococcus pneumoniae to beta-lactam antibiotics\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Gram-positive rods such as Listeria",
"     </li>",
"     <li>",
"      Gram-negative cocci such as Neisseria sp (except penicillinase-producing Neisseria gonorrhoeae)",
"     </li>",
"     <li>",
"      Most anaerobes (with certain exceptions, such as Bacteroides)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"     Penicillin G",
"    </a>",
"    is only bacteriostatic for enterococci; reports document strains with increasing intrinsic resistance to penicillin and, rarely, with high level resistance due to penicillinase production [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1110/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/56/26506?source=see_link\">",
"     \"Mechanisms of antibiotic resistance in enterococci\"",
"    </a>",
"    .) Serious infections with enterococci are generally treated with combination therapy of a cell wall active antibiotic such as penicillin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    (unless high level resistance to these aminoglycosides is present). Penicillin G is not active against gram-negative bacilli because of poor penetration through the porin channel. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/2/26663?source=see_link&amp;anchor=H3#H3\">",
"     \"Beta-lactam antibiotics: Mechanisms of action and resistance and adverse effects\", section on 'Mechanisms of bacterial resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Antistaphylococcal penicillins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antistaphylococcal penicillins (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/36/1608?source=see_link\">",
"     nafcillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"     oxacillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/45/31446?source=see_link\">",
"     cloxacillin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=see_link\">",
"     dicloxacillin",
"    </a>",
"    ) inhibit penicillinase-producing staphylococci but are inactive against oxacillin-resistant staphylococci [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1110/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=see_link\">",
"     \"Microbiology of methicillin-resistant Staphylococcus aureus\"",
"    </a>",
"    .) However, for strains of S. aureus sensitive to oxacillin, antistaphylococcal penicillins are preferable to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    because vancomycin is less active against S. aureus than beta-lactams in in vitro and clinical studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1110/abstract/8\">",
"     8",
"    </a>",
"    ]. Antistaphylococcal penicillins have less intrinsic activity than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"     penicillin G",
"    </a>",
"    for most bacteria and are ineffective for enterococci, Listeria, and Neisseria sp.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Broad spectrum penicillins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The broad spectrum penicillins are distinguished by their activity against gram-negative bacilli. These agents have been stratified into the second-generation penicillins (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    and related agents), the third-generation penicillins (carbenicillin and ticarcillin), and the fourth-generation penicillin",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"     piperacillin",
"    </a>",
"    . None of the broad spectrum penicillins is effective against penicillinase-producing staphylococci.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Second generation",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     Ampicillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    , and closely related antibiotics are able to penetrate the porin channel of gram-negative bacteria but are not stable to beta-lactamases. These antibiotics are active against the majority of strains of Escherichia coli, Proteus mirabilis, Salmonella, Shigella, and Haemophilus influenzae. While a large percentage of encapsulated H. influenzae type b from the blood and cerebrospinal fluid (CSF) of children are beta-lactamase positive (and ampicillin resistant), only 15 percent of the non-type b isolates from adult patients with community-acquired pneumonia are beta-lactamase positive [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1110/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"     Amoxicillin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    have an identical spectrum of activity, but amoxicillin is better absorbed from the intestine when administered orally and yields higher blood and urine levels. Amoxicillin is available generically and is preferable to ampicillin for oral use except in the therapy of Shigella infections sensitive to ampicillin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39334?source=see_link\">",
"     \"Treatment and prevention of Shigella infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Third generation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carbenicillin and ticarcillin also can penetrate the porin channel of gram-negative bacteria in high doses, but they are less active than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    on a weight basis. However, the carboxy group on the side chain of these antibiotics expands the spectrum of activity by rendering them more resistant to the chromosomal beta-lactamases of certain organisms, such as indole-positive Proteus species, Enterobacter species, and Pseudomonas aeruginosa. Third and fourth generation penicillins are most useful in infections caused by these organisms.",
"   </p>",
"   <p>",
"    Carbenicillin indanyl sodium is an orally absorbed form of carbenicillin which may be indicated for oral therapy of resistant urinary tract infections; the usual dose is one or two tablets (382 mg each) four times a day. Oral carbenicillin is not effective for therapy of infections outside of the urinary tract. Carbenicillin is not available any more for parenteral use.",
"   </p>",
"   <p>",
"    Ticarcillin has the same spectrum of activity as carbenicillin but is two to four times more active on a weight basis against P. aeruginosa; the normal maximum parenteral dose is 18",
"    <span class=\"nowrap\">",
"     g/day.",
"    </span>",
"    Ticarcillin is a disodium salt (which may cause a problem in patients with volume overload) and may cause a bleeding diathesis by inhibition of platelet function and prolongation of the bleeding time. Ticarcillin is usually administered now in combination with a beta-lactamase inhibitor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44789?source=see_link&amp;anchor=H2#H2\">",
"     \"Combination beta-lactamase inhibitors, carbapenems, and monobactams\", section on 'Beta-lactamase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Fourth generation",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"     Piperacillin",
"    </a>",
"    is a derivative of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1110/abstract/10\">",
"     10",
"    </a>",
"    ]. It covers much the same spectrum as carbenicillin and ticarcillin but is more active in vitro on a weight basis. In addition, it has some activity against strains of Klebsiella, although cephalosporins remain the preferred agents. It is more active than carbenicillin or ticarcillin against enterococci and Bacteroides fragilis, but other agents are preferred for the treatment of these organisms as well.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"     Piperacillin",
"    </a>",
"    is somewhat more active against Enterobacteriaceae than carbenicillin or ticarcillin and more active than ticarcillin against P. aeruginosa. As with ticarcillin, clinical failures have occurred when piperacillin is used as a single agent to treat serious Pseudomonas infections. Piperacillin is usually administered now in combination with a beta-lactamase inhibitor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44789?source=see_link&amp;anchor=H2#H2\">",
"     \"Combination beta-lactamase inhibitors, carbapenems, and monobactams\", section on 'Beta-lactamase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The third and fourth-generation penicillins are generally considered together as anti-Pseudomonal penicillins [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1110/abstract/11\">",
"     11",
"    </a>",
"    ] and only a single representative employed as standard therapy at a given hospital. Several factors enter the decision over which of these agents to choose:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"       Piperacillin",
"      </a>",
"      is more active in vitro on a weight basis in inhibiting bacterial growth but not in bacterial killing; for P. aeruginosa, ticarcillin is more rapidly bactericidal",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"       Piperacillin",
"      </a>",
"      has little enhanced stability to beta-lactamases compared with ticarcillin",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"       Piperacillin",
"      </a>",
"      has less effect than ticarcillin on platelet function",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    None of these factors clearly favor one of these drugs over the others; thus, the choice of one for standard therapy in an institution may primarily be made based upon cost considerations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The half-lives of the penicillins are similar and all achieve adequate levels in most bodily fluids, but dose adjustment with renal insufficiency depends upon the presence of non-renal routes of excretion and differs among these drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Half-life",
"    </span>",
"    &nbsp;&mdash;&nbsp;All of the available penicillins have relatively short half-lives (generally one hour or less); all of the parenteral agents are usually administered on an every four hour basis when treating serious systemic infections in patients with normal renal function.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"     Piperacillin",
"    </a>",
"    has dose-dependent pharmacokinetics and a longer half-life when higher doses are administered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Levels in different bodily fluids",
"    </span>",
"    &nbsp;&mdash;&nbsp;All of the penicillins achieve therapeutic levels in pleural, pericardial, peritoneal and synovial fluids, as well as urine. All achieve levels in bile higher than corresponding serum levels (assuming the absence of obstruction);",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/36/1608?source=see_link\">",
"     nafcillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"     piperacillin",
"    </a>",
"    achieve very high levels in bile.",
"   </p>",
"   <p>",
"    The penicillins penetrate the CSF poorly in the absence of inflammation but achieve therapeutic levels in patients with meningitis who are given meningeal doses of parenteral therapy (",
"    <a class=\"graphic graphic_table graphicRef51256 \" href=\"UTD.htm?3/14/3307\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link&amp;anchor=H11#H11\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\", section on 'Drug entry into CSF'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Dose adjustment with renal insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/36/1608?source=see_link\">",
"     Nafcillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"     oxacillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/45/31446?source=see_link\">",
"     cloxacillin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=see_link\">",
"     dicloxacillin",
"    </a>",
"    have major non-renal routes of clearance and need no dose modification even in the presence of severe renal failure.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     Ampicillin",
"    </a>",
"    and the structurally related antibiotic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"     piperacillin",
"    </a>",
"    , require dose modification predominantly when the GFR is below 10",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"    Ticarcillin requires dose modification when the GFR is below 50",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    dosing (",
"    <a class=\"graphic graphic_table graphicRef63839 \" href=\"UTD.htm?5/20/5451\">",
"     table 2",
"    </a>",
"    ) and adjustment of dose in the patient with renal dysfunction (",
"    <a class=\"graphic graphic_table graphicRef79502 \" href=\"UTD.htm?9/59/10171\">",
"     table 3",
"    </a>",
"    ) of the newer penicillins are shown in the Tables.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8071173\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"       Penicillin G",
"      </a>",
"      is highly active against most Gram-positive cocci, Gram-positive rods, Gram-negative cocci, and anaerobes. Exceptions are bacteria from these classes that have acquired resistance to penicillin as well as certain anaerobes that produce a beta-lactamase such as Bacteroides. Penicillin is only bacteriostatic against enterococci. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Penicillin G'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For strains of S. aureus sensitive to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"       oxacillin",
"      </a>",
"      , antistaphylococcal penicillins are preferable to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      because they are more active in vitro and in clinical studies. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Antistaphylococcal penicillins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Broad spectrum penicillins have increased activity over",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"       penicillin G",
"      </a>",
"      against Gram-negative bacilli but are variably inactivated by beta-lactamases. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Broad spectrum penicillins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All penicillins have relatively short half-lives and require frequent administration when given parenterally. CSF penetration is poor except in the presence of inflammation. The anti-staphylococcal penicillins need no dose modification when used in the setting of renal failure. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Pharmacology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/1\">",
"      Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997; 24 Suppl 1:S85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/2\">",
"      Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994; 331:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/3\">",
"      Bradley JS, Scheld WM. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clin Infect Dis 1997; 24 Suppl 2:S213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/4\">",
"      Pallares R, Li&ntilde;ares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/5\">",
"      Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343:1917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/6\">",
"      Herman DJ, Gerding DN. Antimicrobial resistance among enterococci. Antimicrob Agents Chemother 1991; 35:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/7\">",
"      Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993; 94:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/8\">",
"      Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/9\">",
"      Jorgensen JH, Doern GV, Maher LA, et al. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990; 34:2075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/10\">",
"      Bush LM, Johnson CC. Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations. Infect Dis Clin North Am 2000; 14:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1110/abstract/11\">",
"      Tan JS, File TM Jr. Antipseudomonal penicillins. Med Clin North Am 1995; 79:679.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 473 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-A7B94B43F3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1110=[""].join("\n");
var outline_f1_5_1110=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8071173\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SPECTRUM OF ACTIVITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Penicillin G",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Antistaphylococcal penicillins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Broad spectrum penicillins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Second generation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Third generation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Fourth generation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PHARMACOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Half-life",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Levels in different bodily fluids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Dose adjustment with renal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8071173\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/473\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/473|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/14/3307\" title=\"table 1\">",
"      CSF concentrations penicillins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/20/5451\" title=\"table 2\">",
"      Dosing of newer penicillins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/59/10171\" title=\"table 3\">",
"      Max doses PCNs in renal failure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/2/26663?source=related_link\">",
"      Beta-lactam antibiotics: Mechanisms of action and resistance and adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38519?source=related_link\">",
"      Cephalosporins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44789?source=related_link\">",
"      Combination beta-lactamase inhibitors, carbapenems, and monobactams",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=related_link\">",
"      Initial therapy and prognosis of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/56/26506?source=related_link\">",
"      Mechanisms of antibiotic resistance in enterococci",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=related_link\">",
"      Microbiology of methicillin-resistant Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/5/81?source=related_link\">",
"      Resistance of Streptococcus pneumoniae to beta-lactam antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39334?source=related_link\">",
"      Treatment and prevention of Shigella infection in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_5_1111="L H Reed Sternberg cells";
var content_f1_5_1111=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F63097&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F63097&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    \"Lymphocytic and histiocytic\" Reed-Sternberg cells in Hodgkin lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 414px; height: 384px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Section of a lymph node from a patient with nodular lymphocyte predominant Hodgkin lymphoma showing three L&amp;H Hodgkin/Reed-Sternberg cells (arrows) with highly iregular polypoid nuclear contours, resembling popped corn. These cells are seen in a background of small lymphocytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Warnke, RA, Weiss, LM, Chan, JK, Cleary, ML, Dorfman, RF. Tumors of the lymph nodes and spleen. Atlas of tumor pathology (electronic fascicle). Third series, fascicle 14, 1995, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1111=[""].join("\n");
var outline_f1_5_1111=null;
var title_f1_5_1112="Pathogenesis ebola Marburg";
var content_f1_5_1112=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F57590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F57590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of Ebola and Marburg hemorrhagic fevers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 698px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    .",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1112=[""].join("\n");
var outline_f1_5_1112=null;
var title_f1_5_1113="Subdivisions pharynx";
var content_f1_5_1113=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F65105&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F65105&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 620px\">",
"   <div class=\"ttl\">",
"    Subdivisions of the pharynx",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 600px; height: 600px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     <strong>",
"      A)",
"     </strong>",
"     Nasopharynx.",
"     <br>",
"      <strong>",
"       B)",
"      </strong>",
"      Oropharynx.",
"      <br>",
"       <strong>",
"        C)",
"       </strong>",
"       Laryngopharynx (hypopharynx and larynx).",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Anatomical Chart Company. General Anatomy. Copyright &copy;2008 Anatomical Chart Company.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1113=[""].join("\n");
var outline_f1_5_1113=null;
var title_f1_5_1114="Management of stage I and stage II non-small cell lung cancer";
var content_f1_5_1114=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of stage I and stage II non-small cell lung cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/5/1114/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1114/contributors\">",
"     Howard J West, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1114/contributors\">",
"     Eric Valli&egrave;res, MD, FRCSC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1114/contributors\">",
"     Steven E Schild, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/5/1114/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1114/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1114/contributors\">",
"     Brian Kavanagh, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1114/contributors\">",
"     Joseph S Friedberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/5/1114/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/5/1114/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/5/1114/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment for lung cancer depends upon tumor histology (small cell versus non-small cell), extent (stage) and patient specific factors (eg, age, pulmonary function, comorbidity). The major subtypes of non-small cell lung cancer (NSCLC) include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, in decreasing order of frequency of occurrence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link\">",
"     \"Pathology of lung malignancies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with NSCLC who have disease limited to one lung and not involving the mediastinum or more distant sites have localized, stage I or stage II disease (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef68104 \" href=\"UTD.htm?13/4/13388\">",
"     table 2",
"    </a>",
"    ). Stage I plus stage II disease accounts for approximately 30 percent of patients with NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/1\">",
"     1",
"    </a>",
"    ]. In this setting, surgical resection is the primary approach to treatment if there are no contraindications.",
"   </p>",
"   <p>",
"    The approach to treatment of patients with stage I and stage II disease will be reviewed here. Overviews of other aspects of lung cancer are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=see_link\">",
"     \"Overview of the risk factors, pathology, and clinical manifestations of lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13273?source=see_link\">",
"     \"Overview of the initial evaluation, treatment and prognosis of lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tumor node metastasis (TNM) staging system is used for treatment planning and prognostic purposes in patients with NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/2\">",
"     2",
"    </a>",
"    ]. The current (seventh) edition of the TNM system was validated in a large clinical database and correlates better with survival than earlier versions of the TNM staging system (",
"    <a class=\"graphic graphic_figure graphicRef73088 \" href=\"UTD.htm?16/30/16871\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/1\">",
"     1",
"    </a>",
"    ]. The details of the 2010 TNM system, including the classifications for the primary tumor (T) and regional lymph nodes (N), as well as grouping into stages, are presented in the following table (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). The sixth TNM staging system is presented as well for comparison (",
"    <a class=\"graphic graphic_table graphicRef68104 \" href=\"UTD.htm?13/4/13388\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74820 \" href=\"UTD.htm?19/43/20157\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical staging is often unreliable, and patients thought to have stage I or II disease are restaged pathologically following surgery. Pathologic staging of the mediastinal lymph nodes is performed either prior to or at the time of resection. The issue of when to pathologically stage patients with stage I or II disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link&amp;anchor=H109591606#H109591606\">",
"     \"Management of stage III non-small cell lung cancer\", section on 'Mediastinal evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When mediastinal lymph node involvement is detected, patients are reclassified as having stage III disease. In a series of 2994 patients, the concordance between clinical and pathologic stage was only 47 percent for the primary tumor and 47 percent for regional lymph nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H328049\">",
"     'Mediastinal lymph node dissection'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link\">",
"     \"Management of stage III non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is the standard treatment for patients with clinical stage I and II NSCLC, in whom there is no evidence of mediastinal involvement prior to surgical resection. Although the role of surgery has not been validated through randomized trials, the favorable results reported in surgical series and the relative infrequency of long-term survival in patients treated without surgery established surgery as the treatment of choice [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As with malignancies at other sites [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/6\">",
"     6",
"    </a>",
"    ], mortality associated with surgery is decreased and long-term survival is improved in hospitals performing a high volume of lung cancer resections [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adjuvant chemotherapy is often recommended for selected patients with stage II NSCLC and may have a role in a subset of patients with stage IB disease. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Adjuvant chemotherapy'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=see_link\">",
"     \"Adjuvant systemic therapy in resectable non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H473907\">",
"    <span class=\"h2\">",
"     Preoperative evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preoperative evaluation of patients with potentially resectable lung cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/2/15400?source=see_link\">",
"     \"Preoperative evaluation for lung resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Lobectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lobectomy, the surgical resection of a single lobe, is generally accepted as the optimal procedure for early stage NSCLC, because of its ability to preserve pulmonary function [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/8\">",
"     8",
"    </a>",
"    ]. In patients with early stage NSCLC, video-assisted thoracoscopic surgery (VATS) may be an alternative to open thoracotomy for patients undergoing lobectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Videoassisted thoracoscopic surgery'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Proximal tumors may not be readily resected by lobectomy, thereby requiring a more extensive procedure. In this situation, sleeve resection is preferred over pneumonectomy if possible, based upon equivalent oncologic results, better preservation of pulmonary function and avoidance of the complications of pneumonectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32329?source=see_link\">",
"     \"Sequelae and complications of pneumonectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Limited (sublobar) resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A sublobar resection consists of the removal of one or more anatomical segments (segmentectomy) or, more commonly, of a nonanatomical wedge resection. Limited (sublobar) resection may be an option for patients who cannot tolerate a full lobectomy because of severely compromised pulmonary function, advanced age, or other extensive comorbidity. This approach should probably be limited to primary tumors &le;3 cm. Advances in video-assisted thoracoscopic surgery (VATS) facilitated the utilization of limited resections in selected high-risk patients. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Videoassisted thoracoscopic surgery'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Data regarding the relative efficacy of limited resection compared to lobectomy are limited. The best evidence comes from the Lung Cancer Study Group trial 801 in which 276 patients with peripheral T1N0 (stage IA) NSCLC were randomly assigned during surgery to either lobectomy or a more limited procedure (ie, wedge resection, segmentectomy) after intraoperative assessment of hilar and lobar lymph nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/8\">",
"     8",
"    </a>",
"    ]. There was a threefold increase in the rate of local recurrence and a 30 percent increase in mortality (p = 0.08) among those who underwent limited resection compared to lobectomy, particularly in patients with non-squamous cell histology.",
"   </p>",
"   <p>",
"    Retrospective analyses from several studies also have found that survival appears to be lower with limited resection rather than lobectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. While these findings are from retrospective analyses, several prospective nonrandomized studies have reported favorable long-term survival following wedge resection or segmentectomy among patients with peripheral lung cancers 2 cm in size or smaller [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/14-16\">",
"     14-16",
"    </a>",
"    ], including those with bronchioloalveolar carcinoma histology [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The ongoing Cancer and Leukemia Group B (CALGB) trial 140503 (NCT00499330) is directly comparing lobectomy to limited resection among patients with peripheral tumors measuring &le;2 cm (stage IA) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Videoassisted thoracoscopic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Video-assisted thoracoscopic surgery (VATS) is a minimally invasive approach to the treatment of early stage NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/20\">",
"     20",
"    </a>",
"    ]. VATS decreases surgical morbidity, including perioperative pain, and is particularly useful for those with significant medical comorbidities.",
"   </p>",
"   <p>",
"    The decreased morbidity with VATS may enhance compliance with postoperative adjuvant chemotherapy. As an example, in a nonrandomized series of 100 consecutive patients who underwent lobectomy, patients managed with VATS had significantly fewer delayed (18 versus 58 percent with open thoracotomy) and reduced (26 versus 49 percent) chemotherapy doses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=see_link\">",
"     \"Adjuvant systemic therapy in resectable non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the efficacy of VATS compared to conventional surgical techniques has not been definitively established, several large case series and a preliminary report of a multi-institutional study support the safety and efficacy of a VATS lobectomy for patients with stage I NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41414?source=see_link\">",
"     \"An overview of medical thoracoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H328049\">",
"    <span class=\"h2\">",
"     Mediastinal lymph node dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients undergoing mediastinal lymph node evaluation at surgery, the optimal extent of lymph node resection is uncertain. A meta-analysis concluded that systematic mediastinal nodal dissection (levels 4, 7, and 10 for right sided lesions, and levels 5 or 6 and 7 for left sided lesions (",
"    <a class=\"graphic graphic_figure graphicRef73945 \" href=\"UTD.htm?19/28/19914\">",
"     figure 2",
"    </a>",
"    )) was associated with a small to moderate improvement in survival compared with lymph node sampling alone [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/4\">",
"     4",
"    </a>",
"    ]. However, the improved results may simply reflect the improved accuracy of staging [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2006, the European Society of Thoracic Surgeons guidelines recommended systematic lymph node dissection in all cases to ensure complete resection. Lobe specific nodal dissection was considered acceptable for peripheral T1 lesions if hilar and interlobar nodes were negative on frozen section evaluations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/26\">",
"     26",
"    </a>",
"    ]. Similar recommendations were recently proposed by the British Thoracic Society [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The North-American phase III ACOSOG Z0030 trial (NCT00003831) compared strategies of systematic lymph node dissection versus mediastinal lymph node sampling [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/28\">",
"     28",
"    </a>",
"    ]. All patients initially underwent sampling of side-specific hilar and mediastinal lymph nodes. The 1111 patients whose sampled nodes were negative were then randomly assigned to a systematic nodal dissection or not. Systematic lymph node dissection did not improve survival of patients with early stage NSCLC nor did it decrease the incidence of local or regional recurrence. Surprisingly, unsuspected N2 involvement was identified in only 3.8 percent of patients randomly assigned to systematic nodal dissection, possibly a reflection that the prerandomization lymph node sampling may have been quite thorough for many patients on this study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1242764191\">",
"    <span class=\"h2\">",
"     Positive resection margins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with microscopic involvement of the resection margin with tumor (R1) following seemingly complete resection have a significantly poorer prognosis than for those with negative microscopic margins (R0) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/29-33\">",
"     29-33",
"    </a>",
"    ], and postoperative RT may be indicated in this setting. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Postoperative RT'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In rare cases, involvement at the resection margin may be limited to carcinoma in situ (R1(is)). These patients have a significantly better prognosis than those with more extensive disease at the resection margins [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. There is no evidence that RT improves the prognosis in these cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/30\">",
"     30",
"    </a>",
"    ]. The role of radiation in treating patients with resection margins containing only carcinoma in situ is uncertain. There are potential risks and benefits, and ultimately, the decision needs to be individualized for each individual patient. Factors that need to be considered include the patient's stage, character of the tumor, location of the positive margin, the surgeon's impression of the security of stump closure, available radiation oncologic expertise, and the patient's pulmonary and general health.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Chest wall involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with stage IIB (T3N0M0) (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ) disease due to chest wall invasion, en-bloc resection may be indicated. In a series of 212 patients, resection was associated with a 40 percent five-year survival rate [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/34\">",
"     34",
"    </a>",
"    ]. If lymph node involvement was detected at surgery (ie, stage IIIA), the five-year survival rate was only 12 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Local recurrence after surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of local recurrence following surgery for stage I or stage II NSCLC varies from 6 to 55 percent in different studies.",
"   </p>",
"   <p>",
"    The most extensive data come from a study of 975 consecutive patients with T1-T2, N0-N1, M0 primary tumors operated on at a single institution between 1995 and 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/35\">",
"     35",
"    </a>",
"    ]. Local failures were defined as recurrence at the surgical margin, in the ipsilateral hilum, or in the mediastinum, ie, areas that would have been encompassed by postoperative (adjuvant) radiation therapy (RT). The five-year incidence of local recurrence was 23 percent, with a median time to recurrence of 14 months. The five-year risk of any treatment failure was 42 percent, including local",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    distant relapses, as well as second primary lung cancers. The initial sites of treatment failure were local, combined local and distant, and distant only in 25, 29, and 46 percent of cases, respectively. On multivariate analysis, factors significantly associated with an increased risk of local recurrence included wedge resection or segmentectomy rather than lobectomy, squamous or large cell histology, and pathologic stage IB or II rather than IA (hazard ratios 1.99, 1.98, and 2.02, respectively).",
"   </p>",
"   <p>",
"    Patients with a local recurrence without distant metastases may be candidates for additional resection. When more surgery is not an option, patients may benefit from radiation therapy alone or chemoradiotherapy, and overall survival is similar to that with similarly staged patients managed initially with RT [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Definitive RT'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lobectomy is the procedure of choice for patients with stages I and II NSCLC and is preferred over pneumonectomy if the lesion can be completely resected. There are no randomized trials comparing open thoracotomy with VATS.",
"   </p>",
"   <p>",
"    A more limited procedure is appropriate for those who are unable to tolerate conventional lobectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/37\">",
"     37",
"    </a>",
"    ]. Limited resections should be avoided for tumors &gt;3 cm in size whenever possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     NONSURGICAL APPROACHES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various radiation therapy (RT) techniques, radiofrequency ablation, and cryoablation have been used or are being studied as alternatives to surgical resection, particularly for patients with significant comorbidity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Definitive RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Definitive RT is used as the primary treatment modality in patients with NSCLC who have comorbid conditions that preclude safe resection or refuse surgery. Definitive RT is also used in selected patients without distant metastases who have a local recurrence following surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/36\">",
"     36",
"    </a>",
"    ]. Stereotactic body RT (SBRT) is being used more frequently for the definitive management of stage I NSCLC reserving the use of more conventional RT programs for stage II NSCLC. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Stereotactic body radiation therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The results of RT in clinical stage I and II NSCLC are illustrated by a review that included approximately 2000 medically unresectable patients from 26 nonrandomized studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/38\">",
"     38",
"    </a>",
"    ]. Overall survival at two and five years ranged from 22 to 72 and 0 to 42 percent, respectively, while cancer-specific survival was 54 to 93 percent and 13 to 39 percent, respectively. Following RT, between 11 and 43 percent of patients died from noncancer causes, reflecting the poor health status of those included in these studies. Patients who are not candidates for resection are staged clinically; the lack of pathologic staging probably contributes to the poorer outcomes reported with RT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H328491\">",
"    <span class=\"h2\">",
"     Altered fractionation schedules",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple trials have explored the use of altered dose fractionation schedules in order to improve the therapeutic index of RT for NSCLC. These approaches include hyperfractionation (two or three fractions per day with a lower dose per fraction over the standard treatment duration), accelerated fractionation (using a standard fraction size and total radiation dose, given over a shorter overall time), or a combination of hyperfractionation and acceleration.",
"   </p>",
"   <p>",
"    The most extensive information comes from a meta-analysis that incorporated individual patient data from 2000 patients in eight randomized trials, in which patients were randomly assigned to an altered regimen or conventional fractionation (five daily fractions per week of 1.8 to 2.0 Gy, with a minimum dose of 60 Gy) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/39\">",
"     39",
"    </a>",
"    ]. The analysis included 328 patients with stage I or II disease.",
"   </p>",
"   <p>",
"    Modified fractionation resulted in a small, statistically significant, improvement in overall five-year survival (10.8 versus 8.3 percent; hazard ratio 0.88, 95% CI 0.80-0.97); there was no significant difference in results between patients with stage",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    disease and those with stage III disease. However, the modified fractionation schedules resulted in a significantly increased risk of severe esophageal toxicity (19 versus 9 percent, odds ratio 2.44).",
"   </p>",
"   <p>",
"    Modified radiation therapy schedules remain less commonly utilized than a conventional once daily radiation plan, due in part to the logistical challenges for patients and treating centers. Stereotactic body radiation therapy (described below) is more frequently used for stage I disease. For stage II disease, RT is infrequently employed, but a daily or modified fractionation RT approach could be considered for those patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Stereotactic body radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stereotactic body radiation therapy (SBRT) delivers a single or very limited number of high dose fractions to a radiographically discrete treatment volume by using multiple convergent beams. This results in a rapid fall-off of dose at the edge of the target volume and a clinically insignificant dose to adjacent normal tissue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/21/43350?source=see_link&amp;anchor=H2#H2\">",
"     \"Stereotactic body radiation therapy: Rationale and clinical experience\", section on 'Rationale'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Phase II trials in carefully selected patients suggest that SBRT is as effective as surgery. Two phase III randomized trials currently are comparing SBRT with surgery. Although SBRT has not been established as an appropriate alternative to surgical resection in good surgical candidates, SBRT may be useful in elderly patients and those with significant comorbidity who are not candidates for surgery or a protracted course of conventional external beam RT. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17143?source=see_link&amp;anchor=H7#H7\">",
"     \"Stereotactic body radiation therapy for primary and metastatic lung tumors\", section on 'Primary NSCLC'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Heavy particle irradiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both proton beam and carbon ion therapy have been used on an experimental basis in patients with stage I NSCLC. Preliminary results suggest that these approaches may yield results that are similar to conventional RT, but additional experience is required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/45/10968?source=see_link&amp;anchor=H7#H7\">",
"     \"Proton and ion beams in cancer therapy\", section on 'Lung cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Radiofrequency ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation (RFA) utilizes radiowaves that are emitted from a probe implanted within a tumor to generate heat, causing coagulation necrosis of a tumor. This technique has been applied to patients with small primary NSCLCs who are not candidates for surgery.",
"   </p>",
"   <p>",
"    The technique and results with RFA are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25255?source=see_link&amp;anchor=H1222763429#H1222763429\">",
"     \"Radiofrequency ablation of lung tumors\", section on 'Non-small cell lung cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Cryoablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cryoablation is a technique that involves placement of a cryoprobe into a lesion in the lung, with freezing used to cause focal tissue destruction. Although this approach is more widely used in other body locations, cryoablation remains experimental for lung lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/26/20900?source=see_link\">",
"     \"Cryoablation of lung tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ADJUVANT THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both distant metastases and local recurrence can cause morbidity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    death following potentially curative resection of NSCLC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Adjuvant chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple clinical trials utilizing contemporary cisplatin-based regimens demonstrated a survival advantage for patients with stage II disease and suggested a survival benefit for a subset of patients with stage IB NSCLC. The results from these trials do not support the use of adjuvant chemotherapy in patients with stage IA disease outside of a clinical trial, and chemotherapy may actually have a deleterious effect in these patients. These results and recommendations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=see_link&amp;anchor=H11#H11\">",
"     \"Adjuvant systemic therapy in resectable non-small cell lung cancer\", section on 'Platinum-based chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Preoperative (neoadjuvant) chemotherapy has been compared to immediate surgery in a number of phase III trials for patients with resectable NSCLC with inconsistent results. Whether neoadjuvant chemotherapy is inferior, superior, or equivalent to adjuvant (postoperative) chemotherapy is unclear, but postoperative chemotherapy has been better studied and is the prevailing standard of care in appropriate patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=see_link&amp;anchor=H20#H20\">",
"     \"Adjuvant systemic therapy in resectable non-small cell lung cancer\", section on 'Neoadjuvant chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initial studies suggest that molecular techniques, such as gene expression profiling or the detection of DNA methylation markers, may define a subset of patients with stage I disease that are at high risk for relapse. Research using molecular signatures to identify patients who may benefit from postoperative chemotherapy is being incorporated into adjuvant therapy protocols but is not an approach utilized for making clinical decisions at the present time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=see_link&amp;anchor=H4#H4\">",
"     \"Adjuvant systemic therapy in resectable non-small cell lung cancer\", section on 'Molecular markers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Postoperative RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative (adjuvant) RT has been studied to prevent local recurrence following resection of a NSCLC [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/40-44\">",
"     40-44",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Local recurrence after surgery'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The evidence from multiple randomized trials indicates that postoperative RT can reduce the frequency of local recurrence. However, the impact of RT on overall survival is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/40-44\">",
"     40-44",
"    </a>",
"    ]. Both a meta-analysis and a SEER database analysis suggested that postoperative RT may have a detrimental effect on survival [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The variable impact on survival is illustrated by the following trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a trial conducted by the Lung Cancer Study Group, 230 patients underwent complete resection of stage II or stage III squamous cell carcinoma with pathologic staging of the mediastinal lymph nodes and were then randomly assigned to RT or no further therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/40\">",
"       40",
"      </a>",
"      ]. Overall, about 82 percent of patients had T2 primary tumors, and 75 percent had N1 lymph node involvement. There was no difference in overall survival, but patients who had received postoperative RT had a lower frequency of recurrences in the ipsilateral lung or mediastinum compared to those treated with surgery alone (3 versus 41 percent).",
"     </li>",
"     <li>",
"      In a French trial, 728 patients with NSCLC (221 stage I, 180 stage II, and 327 stage III) were randomly assigned to RT or observation following surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/43\">",
"       43",
"      </a>",
"      ]. Five-year survival was significantly worse for those who received RT compared to those treated with surgery alone (30 versus 43 percent, respectively). This difference was due to a significant excess of deaths due to intercurrent disease in those receiving postoperative RT (five-year death rate 31 versus 8 percent). All patients treated with RT received a total dose of 60 Gy. The incidence of non-cancer-related deaths was significantly higher in patients who received &gt;2 Gy per fraction compared to those receiving standard daily fractions (26 versus 16 to 18 percent).",
"      <br/>",
"      <br/>",
"      In a more recent trial that incorporated three-dimensional treatment planning, smaller RT fields, and a more conservative RT fractionation schedule (50.4 Gy in 28 fractions), 104 patients with pathological Stages IA and IB NSCLC were randomly assigned to adjuvant RT or no further treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/44\">",
"       44",
"      </a>",
"      ]. Only one patient treated with RT had a local recurrence (2 percent) compared to 12 in the control group (23 percent). Overall five-year survival was significantly improved with RT (67 versus 58 percent without RT).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These differences in outcome may be related to RT technique",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    patient selection. Postoperative RT clearly reduces the likelihood of locoregional recurrence. We do not recommend postoperative RT following resection of stage I or II NSCLC unless the surgical resection margins are positive. For patients with only carcinoma in situ at the resection margin, the depth of epithelial involvement may also be a consideration [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/47\">",
"     47",
"    </a>",
"    ]. Further trials are needed to confirm the findings seen with optimized RT techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H1242764191\">",
"     'Positive resection margins'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall five-year survival in NSCLC is between 10 and 15 percent, primarily because approximately 70 percent of patients present with either locally advanced (stage III) or distant metastatic (stage IV) disease. The most extensive data relating stage to prognosis come from a series of over 31,000 cases from the Surveillance, Epidemiology and End Results (SEER) database used to validate the 7th TNM staging system (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In that series, survival progressively decreased with increasing clinical stage, with five-year survival rates for stages IA, IB, IIA, and IIB of 50, 43, 36, and 25 percent, respectively (",
"    <a class=\"graphic graphic_figure graphicRef73088 \" href=\"UTD.htm?16/30/16871\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/2\">",
"     2",
"    </a>",
"    ]. The five-year survival rates based upon pathologic staging are higher than those based upon clinical staging (73, 58, 46, and 36 percent for stages IA, IB, IIA, and IIB, respectively).",
"   </p>",
"   <p>",
"    Among patients with stage I and II NSCLC, a number of factors in addition to stage may affect outcome. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Histology, including the presence of isolated tumor cells in regional lymph nodes",
"     </li>",
"     <li>",
"      Tumor grade",
"     </li>",
"     <li>",
"      Molecular markers",
"     </li>",
"     <li>",
"      Comorbidity",
"     </li>",
"     <li>",
"      Hospital case volume",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have given conflicting results, and the preponderance of evidence suggests that histologic type of NSCLC is not a dominant predictor of prognosis when other variables are taken into consideration.",
"   </p>",
"   <p>",
"    The presence of isolated tumor cells in lymph nodes that are detected by immunohistochemistry is not sufficient for reclassification as pathologically positive, and such lymph nodes are classified as pN0 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/48\">",
"     48",
"    </a>",
"    ]. However, patients whose lymph nodes contain such tumor cells appear to have a significantly poorer prognosis than those with negative lymph nodes by immunohistochemistry [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link&amp;anchor=H8#H8\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\", section on 'Regional lymph nodes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=see_link&amp;anchor=H2#H2\">",
"     \"Adjuvant systemic therapy in resectable non-small cell lung cancer\", section on 'Prognosis after resection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H431365636\">",
"    <span class=\"h2\">",
"     Tumor grade",
"    </span>",
"    &nbsp;&mdash;&nbsp;A retrospective review from the Mayo Clinic of clinical outcomes among 5018 patients included a multivariate analysis that revealed that tumor grade was third behind stage and treatment administered in its predictive value for outcome, with a stepwise decrease in survival from well differentiated to moderately differentiated to poorly differentiated to undifferentiated. This same association of poorer outcomes with less well differentiated tumors was also statistically significant in the 1765 patients who were treated with surgery alone [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Molecular markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of molecular markers are being evaluated in patients with NSCLC, in an effort to define prognostic groups and potentially select patients who might benefit from more aggressive therapy. These approaches include both the use of specific markers and multigene panels.",
"   </p>",
"   <p>",
"    As an example, the presence of mutations in the epidermal growth factor receptor (EGFR) is associated with an improved prognosis as well as responsiveness to EGFR tyrosine kinase inhibitors. Other molecular markers also appear to affect prognosis in patients with NSCLC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=see_link&amp;anchor=H4#H4\">",
"     \"Adjuvant systemic therapy in resectable non-small cell lung cancer\", section on 'Molecular markers'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31816?source=see_link\">",
"     \"Initial systemic therapy for advanced non-small cell lung cancer with a mutation in the epidermal growth factor receptor\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Comorbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of comorbidity was illustrated in a report of 451 patients undergoing resection for stage I NSCLC at a single institution over a five year period [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/51\">",
"     51",
"    </a>",
"    ]. The three-year survival rates were significantly worse with increasing severity of comorbidity (86, 75, 69, and 70 percent for no, mild, moderate, and severe levels of comorbidity, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Hospital case volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients operated on for NSCLC at hospitals that perform large numbers of procedures have significantly lower perioperative mortality rates than those treated at lower volume institutions. In one report based upon Medicare claims data, the adjusted odds ratio for mortality in patients treated at hospitals with the highest volume (more than 46 procedures yearly) was 0.70 compared to the lowest volume hospitals (fewer than nine procedures yearly) for lobectomy and 0.62 for patients treated with pneumonectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hospital volume also affects five-year survival. In an analysis of over 2000 patients from the SEER database, five-year survival was better among individuals undergoing resection at high volume centers (44 versus 33 percent, at low volume centers) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     POST THERAPY SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rationale for surveillance following the initial treatment of NSCLC is to detect recurrent disease or a second primary lung cancer early enough so that an intervention can increase survival",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    improve quality of life.",
"   </p>",
"   <p>",
"    There are no randomized trials assessing different surveillance strategies in patients with NSCLC. Available data are illustrated by the following observational studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A lack of survival benefit associated with detecting asymptomatic rather than symptomatic recurrences was suggested in a review of 358 patients who underwent resection [",
"      <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/54\">",
"       54",
"      </a>",
"      ]. Recurrent disease was diagnosed by routine surveillance in 33 patients, of whom 10 were candidates for potentially curative surgery. A similar percentage of patients with a symptomatic recurrence (30 of 102) underwent surgery. Although the median survival duration from the date of recurrence was eight months longer in patients diagnosed with an asymptomatic recurrence, this probably reflects lead-time bias. In a multivariate analysis, the mode of presentation (symptomatic versus asymptomatic) was not a significant predictor of survival. The authors concluded that routine radiologic imaging follow-up was of questionable value.",
"     </li>",
"     <li>",
"      The same conclusion was reached in a retrospective review of 130 patients, 67 of whom were followed with a strict follow-up policy (examination, chest x-ray, biannual CT) and the remainder evaluated only if symptoms developed [",
"      <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/55\">",
"       55",
"      </a>",
"      ]. Mortality was the same in both groups.",
"     </li>",
"     <li>",
"      The only prospective study included 192 patients who had a chest x-ray every three months and bronchoscopy plus CT scans every six months [",
"      <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/56\">",
"       56",
"      </a>",
"      ]. Of the 136 patients with recurrent NSCLC, 85 were diagnosed by a scheduled procedure, 36 of whom were asymptomatic. Despite the frequency of monitoring, 50 patients developed interval symptoms, leading to documentation of recurrence by an unscheduled procedure. More than twice as many thoracic recurrences documented by a scheduled test were eligible for potentially curative resection (22 of 85 versus 6 of 51 [26 versus 12 percent]).",
"      <br/>",
"      <br/>",
"      Overall, 13 percent of patients with recurrent disease survived three years. In multivariate analysis, the median survival from the date of recurrence was significantly longer among patients with asymptomatic compared to symptomatic recurrence (19 versus 6 months), and among those who could be treated with curative intent surgery versus palliation or supportive care. The authors concluded that intensive follow-up may improve survival by early detection of potentially curable recurrences.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The evidence from these studies and a systematic review of the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/57\">",
"     57",
"    </a>",
"    ] does not establish a clear cut benefit for aggressive surveillance following treatment with curative intent. We suggest a history, physical examination, and chest CT every four to six months for the first two years, and annually thereafter. These recommendations are consistent with guidelines from the National Comprehensive Cancer Network (NCCN) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/5/1114/abstract/58\">",
"     58",
"    </a>",
"    ]. When planning the posttreatment surveillance strategy, care should be taken to limit the number of CT scans if possible, particularly in younger individuals, given concerns about second malignancies induced by radiation exposure. The specific follow-up schedule for CT imaging for an individual patient may be more or less frequent, depending upon risk factors for recurrence (eg, stage, histological features, PET characteristics, etc.) (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/44/3779?source=see_link\">",
"       \"Patient information: Non-small cell lung cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/22/41314?source=see_link\">",
"       \"Patient information: Non-small cell lung cancer treatment; stage I to III cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?16/63/17396?source=see_link\">",
"       \"Patient information: Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Only a minority of patients with non-small cell lung cancer (NSCLC) have pathologic stage I and II disease when diagnosed (",
"    <a class=\"graphic graphic_table graphicRef80099 \" href=\"UTD.htm?36/41/37533\">",
"     table 1",
"    </a>",
"    ). In contrast to locally advanced (stage III) and disseminated (stage IV) disease, early stage disease is frequently curable with aggressive therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Mediastinal staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic staging of the mediastinum is required prior to definitive treatment for clinical stage I and II disease, either as a separate procedure or as the initial step in a planned surgical resection. Patients with mediastinal lymph involvement are restaged as pathologic stage III and are treated accordingly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link\">",
"     \"Management of stage III non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Surgical candidates",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with adequate pulmonary function and without serious medical comorbidity, we recommend surgical resection as the initial treatment for patients with stage I or II NSCLC rather than medical management or conventional radiation therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Ablative procedures such as stereotactic body radiation therapy (SBRT) or radiofrequency ablation (RFA) are experimental in patients who are surgical candidates. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Surgery'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17143?source=see_link&amp;anchor=H7#H7\">",
"       \"Stereotactic body radiation therapy for primary and metastatic lung tumors\", section on 'Primary NSCLC'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25255?source=see_link\">",
"       \"Radiofrequency ablation of lung tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients undergoing surgery, we recommend lobectomy rather than a more limited procedure (ie, wedge resection or segmentectomy) if the patient has an adequate pulmonary reserve (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Pneumonectomy or sleeve resection is required for proximal tumors that cannot be resected by lobectomy. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Lobectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Video-assisted thoracoscopy (VATS) is associated with decreased operative morbidity and a faster recovery. VATS may be a suitable option for selected patients, although its equivalence to open resection has been demonstrated only in single institution retrospective series and small prospective trials. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Videoassisted thoracoscopic surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with tumor involving the mediastinal lymph nodes in the final surgical specimen are classified as pathologic stage III and treated accordingly. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link\">",
"       \"Management of stage III non-small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Nonsurgical candidates",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with small primary tumors (less than 3 to 4 cm) and impaired pulmonary function or medical comorbidity that precludes surgical resection, we suggest ablative therapy with SBRT or RFA rather than definitive radiation therapy, if appropriate technical expertise is available (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17143?source=see_link&amp;anchor=H7#H7\">",
"       \"Stereotactic body radiation therapy for primary and metastatic lung tumors\", section on 'Primary NSCLC'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25255?source=see_link\">",
"       \"Radiofrequency ablation of lung tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with larger primary tumors and impaired pulmonary function or medical comorbidity that precludes surgical resection, we recommend definitive radiation therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Definitive RT'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Adjuvant therapy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend adjuvant chemotherapy with a cisplatin-based doublet after complete resection of stage II NSCLC (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=see_link&amp;anchor=H11#H11\">",
"       \"Adjuvant systemic therapy in resectable non-small cell lung cancer\", section on 'Platinum-based chemotherapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with stage IB NSCLC who are willing and able to tolerate adjuvant chemotherapy, we suggest adjuvant chemotherapy with a platinum-based doublet, particularly for primary tumors measuring 4 cm or larger in greatest diameter, although observation is a reasonable alternative (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). The evidence from individual trials supporting the use of adjuvant therapy is conflicting, although a meta-analysis provides additional support for this approach. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=see_link&amp;anchor=H12#H12\">",
"       \"Adjuvant systemic therapy in resectable non-small cell lung cancer\", section on 'LACE meta-analysis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We recommend not administering adjuvant chemotherapy following resection of stage IA disease, except in the context of a properly-designed clinical trial (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Adjuvant chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend not giving adjuvant RT following complete resection of stage I and II NSCLC with negative resection margins (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Postoperative RT'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend postoperative RT for patients with positive surgical resection margins (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1242764191\">",
"       'Positive resection margins'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Postoperative RT'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Surveillance",
"    </span>",
"    &nbsp;&mdash;&nbsp;After the initial treatment, we suggest a history, physical examination, and periodic chest CT imaging (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ). The frequency of chest CT imaging may vary depending upon the risk of recurrence. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Post therapy surveillance'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/1\">",
"      Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/2\">",
"      Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/3\">",
"      L&oacute;pez-Encuentra A, Garc&iacute;a-Luj&aacute;n R, Rivas JJ, et al. Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg 2005; 79:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/4\">",
"      Manser R, Wright G, Hart D, et al. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev 2005; :CD004699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/5\">",
"      Raz DJ, Zell JA, Ou SH, et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007; 132:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/6\">",
"      Birkmeyer JD. Improving outcomes with lung cancer surgery: selective referral or quality improvement? Ann Surg Oncol 2009; 16:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/7\">",
"      Cheung MC, Hamilton K, Sherman R, et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol 2009; 16:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/8\">",
"      Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/9\">",
"      Yan TD, Black D, Bannon PG, McCaughan BC. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol 2009; 27:2553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/10\">",
"      Ferguson MK, Lehman AG. Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques. Ann Thorac Surg 2003; 76:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/11\">",
"      Mery CM, Pappas AN, Bueno R, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005; 128:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/12\">",
"      Okami J, Ito Y, Higashiyama M, et al. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. Ann Thorac Surg 2010; 90:1651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/13\">",
"      Billmeier SE, Ayanian JZ, Zaslavsky AM, et al. Predictors and outcomes of limited resection for early-stage non-small cell lung cancer. J Natl Cancer Inst 2011; 103:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/14\">",
"      El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006; 82:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/15\">",
"      Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg 1997; 114:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/16\">",
"      Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg 2003; 75:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/17\">",
"      Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg 2003; 75:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/18\">",
"      Yamato Y, Tsuchida M, Watanabe T, et al. Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann Thorac Surg 2001; 71:971.",
"     </a>",
"    </li>",
"    <li>",
"     National Institutes of Health Clinical Trials database. file://www.clinicaltrials.gov/ (Accessed on February 08, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/20\">",
"      Mentzer SJ, DeCamp MM, Harpole DH Jr, Sugarbaker DJ. Thoracoscopy and video-assisted thoracic surgery in the treatment of lung cancer. Chest 1995; 107:298S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/21\">",
"      Petersen RP, Pham D, Burfeind WR, et al. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. Ann Thorac Surg 2007; 83:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/22\">",
"      McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006; 81:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/23\">",
"      Swanson SJ, Herndon JE 2nd, D'Amico TA, et al. Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study. J Clin Oncol 2007; 25:4993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/24\">",
"      Flores RM, Park BJ, Dycoco J, et al. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg 2009; 138:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/25\">",
"      Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003; 21:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/26\">",
"      Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006; 30:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/27\">",
"      Lim E, Baldwin D, Beckles M, et al. Guidelines on the radical management of patients with lung cancer. Thorax 2010; 65 Suppl 3:iii1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/28\">",
"      Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011; 141:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/29\">",
"      Robinson BM, Kennedy C, McLean J, McCaughan BC. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases. J Thorac Oncol 2011; 6:1691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/30\">",
"      Valli&egrave;res E, Van Houtte P, Travis WD, et al. Carcinoma in situ at the bronchial resection margin: a review. J Thorac Oncol 2011; 6:1617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/31\">",
"      Kawaguchi T, Watanabe S, Kawachi R, et al. The impact of residual tumor morphology on prognosis, recurrence, and fistula formation after lung cancer resection. J Thorac Oncol 2008; 3:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/32\">",
"      Massard G, Doddoli C, Gasser B, et al. Prognostic implications of a positive bronchial resection margin. Eur J Cardiothorac Surg 2000; 17:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/33\">",
"      Snijder RJ, Brutel de la Rivi&egrave;re A, Elbers HJ, van den Bosch JM. Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin. Ann Thorac Surg 1998; 65:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/34\">",
"      Doddoli C, D'Journo B, Le Pimpec-Barthes F, et al. Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies. Ann Thorac Surg 2005; 80:2032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/35\">",
"      Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer 2009; 115:5218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/36\">",
"      Cai XW, Xu LY, Wang L, et al. Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2010; 76:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/37\">",
"      British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/38\">",
"      Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev 2001; :CD002935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/39\">",
"      Mauguen A, Le P&eacute;choux C, Saunders MI, et al. Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. J Clin Oncol 2012; 30:2788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/40\">",
"      Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. The Lung Cancer Study Group. N Engl J Med 1986; 315:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/41\">",
"      Feng QF, Wang M, Wang LJ, et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys 2000; 47:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/42\">",
"      Stephens RJ, Girling DJ, Bleehen NM, et al. The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. Br J Cancer 1996; 74:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/43\">",
"      Dautzenberg B, Arriagada R, Chammard AB, et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 1999; 86:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/44\">",
"      Trodella L, Granone P, Valente S, et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 2002; 62:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/45\">",
"      Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998; 352:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/46\">",
"      Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006; 24:2998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/47\">",
"      Pasic A, Gr&uuml;nberg K, Mooi WJ, et al. The natural history of carcinoma in situ involving bronchial resection margins. Chest 2005; 128:1736.",
"     </a>",
"    </li>",
"    <li>",
"     Lung. In: American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.253.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/49\">",
"      Rusch VW, Hawes D, Decker PA, et al. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol 2011; 29:4313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/50\">",
"      Sun Z, Aubry MC, Deschamps C, et al. Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases. J Thorac Cardiovasc Surg 2006; 131:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/51\">",
"      Battafarano RJ, Piccirillo JF, Meyers BF, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2002; 123:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/52\">",
"      Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/53\">",
"      Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001; 345:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/54\">",
"      Walsh GL, O'Connor M, Willis KM, et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995; 60:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/55\">",
"      Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest 1999; 115:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/56\">",
"      Westeel V, Choma D, Cl&eacute;ment F, et al. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 2000; 70:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/5/1114/abstract/57\">",
"      Calman L, Beaver K, Hind D, et al. Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis. J Thorac Oncol 2011; 6:1993.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4642 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-200.215.4.194-8300F9CC1D-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1114=[""].join("\n");
var outline_f1_5_1114=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H473907\">",
"      Preoperative evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Lobectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Limited (sublobar) resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Videoassisted thoracoscopic surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H328049\">",
"      Mediastinal lymph node dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1242764191\">",
"      Positive resection margins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Chest wall involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Local recurrence after surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      NONSURGICAL APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Definitive RT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H328491\">",
"      Altered fractionation schedules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Stereotactic body radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Heavy particle irradiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Radiofrequency ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Cryoablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ADJUVANT THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Adjuvant chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Postoperative RT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H431365636\">",
"      Tumor grade",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Molecular markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Comorbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Hospital case volume",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      POST THERAPY SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Mediastinal staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Surgical candidates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Nonsurgical candidates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Adjuvant therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Surveillance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/4642\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4642|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/30/16871\" title=\"figure 1\">",
"      Nonsmall cell lung ca survival by TNM gp",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/28/19914\" title=\"figure 2\">",
"      IASLC lymph node map",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4642|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/41/37533\" title=\"table 1\">",
"      Lung cancer TMN staging 7th edition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/4/13388\" title=\"table 2\">",
"      Changes 7th ed TNM lung ca",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/43/20157\" title=\"table 3\">",
"      Lung cancer TMN staging 6th edition",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/26/17833?source=related_link\">",
"      Adjuvant systemic therapy in resectable non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41414?source=related_link\">",
"      An overview of medical thoracoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/26/20900?source=related_link\">",
"      Cryoablation of lung tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=related_link\">",
"      Diagnosis and staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31816?source=related_link\">",
"      Initial systemic therapy for advanced non-small cell lung cancer with a mutation in the epidermal growth factor receptor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=related_link\">",
"      Management of stage III non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13273?source=related_link\">",
"      Overview of the initial evaluation, treatment and prognosis of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=related_link\">",
"      Overview of the risk factors, pathology, and clinical manifestations of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=related_link\">",
"      Pathology of lung malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/44/3779?source=related_link\">",
"      Patient information: Non-small cell lung cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/22/41314?source=related_link\">",
"      Patient information: Non-small cell lung cancer treatment; stage I to III cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/63/17396?source=related_link\">",
"      Patient information: Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/2/15400?source=related_link\">",
"      Preoperative evaluation for lung resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/45/10968?source=related_link\">",
"      Proton and ion beams in cancer therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25255?source=related_link\">",
"      Radiofrequency ablation of lung tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/36/32329?source=related_link\">",
"      Sequelae and complications of pneumonectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17143?source=related_link\">",
"      Stereotactic body radiation therapy for primary and metastatic lung tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/21/43350?source=related_link\">",
"      Stereotactic body radiation therapy: Rationale and clinical experience",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=related_link\">",
"      Tumor node metastasis (TNM) staging system for non-small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_5_1115="GI Sx disease in athletes";
var content_f1_5_1115=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66975&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66975&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Gastrointestinal symptoms and disease in athletes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Transient abdominal pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastroesophageal reflux disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nausea and vomiting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intestinal ischemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal infections",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1115=[""].join("\n");
var outline_f1_5_1115=null;
var title_f1_5_1116="Incidence CV disease";
var content_f1_5_1116=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Incidence of atherosclerotic cardiovascular events in the Framingham study*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Age",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Cardiovascular disease, all types",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Coronary disease",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Stroke and TIA",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Heart failure",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Peripheral artery disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Men",
"       </td>",
"       <td class=\"subtitle2\">",
"        Women",
"       </td>",
"       <td class=\"subtitle2\">",
"        Men",
"       </td>",
"       <td class=\"subtitle2\">",
"        Women",
"       </td>",
"       <td class=\"subtitle2\">",
"        Men",
"       </td>",
"       <td class=\"subtitle2\">",
"        Women",
"       </td>",
"       <td class=\"subtitle2\">",
"        Men",
"       </td>",
"       <td class=\"subtitle2\">",
"        Women",
"       </td>",
"       <td class=\"subtitle2\">",
"        Men",
"       </td>",
"       <td class=\"subtitle2\">",
"        Women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35 to 64",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        65 to 94",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Age-adjusted average annual incidence per 1000 persons free of the specified disease.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1116=[""].join("\n");
var outline_f1_5_1116=null;
var title_f1_5_1117="Common vulvar lesions 2";
var content_f1_5_1117=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74333&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74333&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Most common vulvar lesions based on morphology (continued)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Morphology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Color",
"       </td>",
"       <td class=\"subtitle1\">",
"        Common diseases",
"       </td>",
"       <td class=\"subtitle1\">",
"        Infection",
"       </td>",
"       <td class=\"subtitle1\">",
"        Malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        Papules, nodules",
"       </td>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        Red",
"       </td>",
"       <td>",
"        Urticaria",
"       </td>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        &nbsp;",
"       </td>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angiomas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angiokeratoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urethral caruncle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Endometriosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Furunculosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflamed cysts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hidradenititis suppurativa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Pustule",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        Folliculitis",
"       </td>",
"       <td>",
"        Candidiasis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Keratosis pilaris",
"       </td>",
"       <td>",
"        Herpes simplex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        Scabies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insect bites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"10\">",
"        Vesicle, bullae, erosion",
"       </td>",
"       <td colspan=\"1\" rowspan=\"10\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        Fixed drug reaction",
"       </td>",
"       <td>",
"        Bullous impetigo",
"       </td>",
"       <td colspan=\"1\" rowspan=\"10\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythema multiforma",
"       </td>",
"       <td>",
"        Herpes simplex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bullous pemphigoid",
"       </td>",
"       <td>",
"        Herpes zoster",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cicatrical pemphigoid",
"       </td>",
"       <td colspan=\"1\" rowspan=\"7\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pemphigus vulgaris",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pemphigus vegetans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidermolysis bullosa acquisita",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lichen sclerosis et atrophicus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lichen planus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        Ulcer",
"       </td>",
"       <td colspan=\"1\" rowspan=\"5\">",
"        &nbsp;",
"       </td>",
"       <td>",
"        Idiopathic",
"       </td>",
"       <td>",
"        Syphilis",
"       </td>",
"       <td>",
"        Basal cell carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trauma",
"       </td>",
"       <td>",
"        Chancroid",
"       </td>",
"       <td>",
"        Squamous cell carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hidradenitis suppurativa",
"       </td>",
"       <td>",
"        Herpes simplex",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bechet's disease",
"       </td>",
"       <td>",
"        Granuloma inguinale",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crohn's disease",
"       </td>",
"       <td>",
"        Lymphogranuloma venereum",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1117=[""].join("\n");
var outline_f1_5_1117=null;
var title_f1_5_1118="Response criteria AML";
var content_f1_5_1118=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Response criteria in acute myeloid leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Category",
"      </td>",
"      <td class=\"subtitle1\">",
"       Definition",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Complete remission (CR)*",
"      </td>",
"      <td>",
"       Bone marrow blasts &lt;5 percent; absence of blasts with Auer rods; absence of extramedullary disease; absolute neutrophil count &gt;1.0 x 10",
"       <sup>",
"        9",
"       </sup>",
"       /L (1000/&micro;L); platelet count &gt;100 x 10",
"       <sup>",
"        9",
"       </sup>",
"       /L (100,000/&micro;L); independence of red cell transfusions",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CR with incomplete recovery (CRi)&bull;",
"      </td>",
"      <td>",
"       All CR criteria except for residual neutropenia (&lt;1.0 x 10",
"       <sup>",
"        9",
"       </sup>",
"       /L (1000/&micro;L)) or thrombocytopenia (&lt;100 x 10",
"       <sup>",
"        9",
"       </sup>",
"       /L (100,000/&micro;L))",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Morphologic leukemia-free state&Delta;",
"      </td>",
"      <td>",
"       Bone marrow blasts &lt;5 percent; absence of blasts with Auer rods; absence of extramedullary disease; no hematologic recovery required",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Partial remission (PR)",
"      </td>",
"      <td>",
"       Relevant in the setting of phase I and II clinical trials only; all hematologic criteria of CR; decrease of bone marrow blast percentage to 5 to 25 percent; and decrease of pretreatment bone marrow blast percentage by at least 50 percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cytogenetic CR (CRc)&loz;",
"      </td>",
"      <td>",
"       Reversion to a normal karyotype at the time of morphologic CR (or CRi) in cases with an abnormal karyotype at the time of diagnosis; based on the evaluation of 20 metaphase cells from bone marrow",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Molecular CR (CRm)&sect;",
"      </td>",
"      <td>",
"       No standard definition; depends on molecular target",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Treatment failure",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Resistant disease (RD)",
"      </td>",
"      <td>",
"       Failure to achieve CR or CRi (general practice; phase II/III trials), or failure to achieve CR, CRi or PR (phase I trials); only includes patients surviving &ge;7 days following completion of initial treatment, with evidence of persistent leukemia by blood and/or bone marrow examination",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Death in aplasia",
"      </td>",
"      <td>",
"       Deaths occurring &ge;7 days following completion of initial treatment while cytopenic; with an aplastic or hypoplastic bone marrow obtained within 7 days of death, without evidence of persistent leukemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Death from indeterminate cause",
"      </td>",
"      <td>",
"       Deaths occurring before completion of therapy, or &lt;7 days following its completion; or deaths occurring &ge;7 days following completion of initial therapy with no blasts in the blood, but no bone marrow examination available",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Relapse&yen;",
"      </td>",
"      <td>",
"       Bone marrow blasts &ge;5 percent; or reappearance of blasts in the blood; or development of extramedullary disease",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Definitions of response criteria are based primarily on those given by Cheson et al",
"    <sup>",
"     [2]",
"    </sup>",
"    .",
"    <div class=\"footnotes\">",
"     * All criteria need to be fulfilled; marrow evaluation should be based on a count of 200 nucleated cells in an aspirate with spicules; if ambiguous, consider repeat exam after 5 to 7 days; flow cytometric evaluation may help to distinguish between persistent leukemia and regenerating normal marrow; a marrow biopsy should be performed in cases of dry tap, or if no spicules are obtained; no minimum duration of response required.",
"     <br>",
"      &bull; The criterion of CRi is of value in protocols using intensified induction or double induction strategies, in which hematologic recovery is not awaited, but intensive therapy will be continued. In such protocols, CR may even not be achieved in the course of the entire treatment plan. In these instances, the overall remission rate should include CR and CRi patients. Some patients may not achieve complete hematologic recovery upon longer observation times.",
"      <br>",
"       &Delta; This category may be useful in the clinical development of novel agents within phase I clinical trials, in which a transient morphologic leukemia-free state may be achieved at the time of early response assessment.",
"       <br>",
"        &loz; Four studies showed that failure to convert to a normal karyotype at the time of CR predicts inferior outcome.",
"        <sup>",
"         [3-6]",
"        </sup>",
"        <br>",
"         &sect; As an example, in CBF AML low-level PCR-positivity can be detected in patients even in long-term remission. Normalizing to 10",
"         <sup>",
"          4",
"         </sup>",
"         copies of ABL1 in accordance with standardized criteria, transcript levels below 10 to 12 copies appear to be predictive for long-term remission.",
"         <sup>",
"          [7-9]",
"         </sup>",
"         <br>",
"          &yen; In cases with low blast percentages (5 to 10 percent), a repeat marrow should be performed to confirm relapse. Appearance of new dysplastic changes should be closely monitored for emerging relapse. In a patient who has been recently treated, dysplasia or a transient increase in blasts may reflect a chemotherapy effect and recovery of hematopoiesis. Cytogenetics should be tested to distinguish true relapse from therapy-related MDS/AML.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     1. This research was originally published in Blood. Dohner, H, Estey, EH, Amadori, S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel on behalf of the European LeukemiaNet. Blood 2009. Copyright &copy; American Society of Hematology.",
"     <br>",
"      2. Cheson, BD, Bennett, JM, Kopecky, KJ, et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003; 21:4642.",
"      <br>",
"       3. Freireich, EJ, Cork, A, Stass, SA, et al. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. Leukemia 1992; 6:500.",
"       <br>",
"        4. Grimwade, D, Walker, H, Oliver, F, et al. What happens subsequently in AML when cytogenetic abnormalities persist at bone marrow harvest? Results of the 10th UK MRC AML trial. Bone Marrow Transplant 1997; 19:1117.",
"        <br>",
"         5. Marcucci, G, Mr&oacute;zek, K, Ruppert, AS, et al. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from Cancer and Leukemia Group B study 8461. J Clin Oncol 2004; 22:2410.",
"         <br>",
"          6. Balleisen, S, Kuendgen, A, Hildebrandt, B, et al. Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy. Leuk Res 2009; 33:1189.",
"          <br>",
"           7. Freeman, SD, Jovanovic, JV, Grimwade, D. Development of minimal residual disease-directed therapy in acute myeloid leukemia. Semin Oncol 2008; 35:388.",
"           <br>",
"            8. Perea, G, Lasa, A, Avent&iacute;n, A, et al. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]. Leukemia 2006; 20:87.",
"            <br>",
"             9. Martinelli, G, Rondoni, M, Buonamici, S, et al. Molecular monitoring to identify a threshold of CBF&beta;/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv(16) is likely [letter]. Haematologica 2004; 89:495.",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1118=[""].join("\n");
var outline_f1_5_1118=null;
var title_f1_5_1119="Lupus vulgaris papule";
var content_f1_5_1119=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F64828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F64828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lupus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 296px; height: 250px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Papular lesion of lupus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the Research Institute for Tropical Medicine, Philippines.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_5_1119=[""].join("\n");
var outline_f1_5_1119=null;
